NBC SECURITIES, INC.

Broker-Dealer

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 791540 BIRMINGHAM, AL

Position in REGN

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$271,239

-$65,632 QoQ

Shares Held

435

-0.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#966

of 1,322 holders

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NBC SECURITIES, INC. holds $5,111,855 across 54 Biotechnology names. REGN ranks #7 (5.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc.	10,414	$815,103
2	AXSM	Axsome Therapeutics, Inc.	1,623	$397,261
3	TSHA	Taysha Gene Therapies, Inc.	55,022	$374,699
4	INBX	Inhibrx Biosciences, Inc.	3,900	$369,525
5	PTGX	Protagonist Therapeutics, Inc	2,545	$311,966
6	MIRM	Mirum Pharmaceuticals, Inc.	2,591	$303,328
7	REGN	Regeneron Pharmaceuticals, Inc. This page	435	$271,239
8	SRRK	Scholar Rock Holding Corp	4,479	$246,345

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$271,239	435	-0.2%	Shares	Sole	2026-07-21
2026-03-31	$336,871	436	-4.6%	Shares	Sole	2026-04-14
2025-12-31	$352,744	457	-8.6%	Shares	Sole	2026-01-29
2025-09-30	$281,135	500	+449.5%	Shares	Sole	2025-11-14
2025-06-30	$47,775	91	-26.0%	Shares	Sole	2025-07-08
2025-03-31	$78,010	123	-23.1%	Shares	Sole	2025-04-09
2024-09-30	$168,198	160	-20.8%	Shares	Sole	2024-10-15
2024-06-30	$212,308	202	0.0%	Shares	Sole	2024-07-10
2024-03-31	$194,422	202	+0.5%	Shares	Sole	2024-04-05
2023-12-31	$176,536	201	0.0%	Shares	Sole	2024-02-07
2023-09-30	$165,414	201	—	Shares	Sole	2023-11-03
No filing history on record for this holder in this stock.